| Literature DB >> 36210434 |
Kedi Jiao1, Chunmei Wang2, Meizhen Liao3, Jing Ma1, Dianmin Kang4, Weiming Tang5, Joseph D Tucker6,7, Wei Ma8.
Abstract
BACKGROUND: Antiretroviral therapy (ART) adherence is still suboptimal among some key populations, highlighting the need for innovative tailored strategies. This randomized controlled trial (RCT) aimed to evaluate the effect of a differentiated digital intervention on ART adherence among men who have sex with men (MSM) living with HIV in China.Entities:
Keywords: Anti-retroviral agents; Digital technology; Medication adherence; Randomized controlled trial; Sexual and gender minorities; Therapeutics
Mesh:
Substances:
Year: 2022 PMID: 36210434 PMCID: PMC9549628 DOI: 10.1186/s12916-022-02538-3
Source DB: PubMed Journal: BMC Med ISSN: 1741-7015 Impact factor: 11.150
Fig. 1Stratified block randomization profile
Fig. 2Differentiated digital intervention profile
Fig. 3Trial profile
Sociodemographic, behavioral, and clinical characteristics of the study participants in a randomized controlled trial of differentiated digital intervention in China, 2020–2021
| Characteristics | Total ( | Intervention arm ( | Control arm ( |
|---|---|---|---|
| ≤ 30 | 214 (37.2) | 101 (35.1) | 113 (39.2) |
| 31–40 | 246 (42.7) | 128 (44.4) | 118 (41.0) |
| > 40 | 116 (20.1) | 59 (20.5) | 57 (19.8) |
| High school or below | 222 (38.5) | 118 (41.0) | 104 (36.1) |
| College or beyond | 353 (61.3) | 169 (58.7) | 184 (63.9) |
| Missing value | 1 (0.2) | 1 (0.3) | 0 (0.0) |
| ≤ 9474 | 276 (47.9) | 148 (51.4) | 128 (44.4) |
| 9475–15158 | 177 (30.7) | 82 (28.5) | 95 (33.0) |
| > 15158 | 123 (21.4) | 58 (20.1) | 65 (22.6) |
| Unmarried/divorced/widowed | 465 (80.7) | 221 (76.7) | 244 (84.7) |
| Married/cohabitating | 111 (19.3) | 67 (23.3) | 44 (15.3) |
| Gay | 348 (60.4) | 164 (56.9) | 184 (63.9) |
| Bisexual | 151 (26.2) | 80 (27.8) | 71 (24.7) |
| Heterosexual or others | 77 (13.4) | 44 (15.3) | 33 (11.4) |
| Yes | 322 (55.9) | 169 (58.7) | 153 (53.1) |
| No | 254 (44.1) | 119 (41.3) | 135 (46.9) |
| Yes | 359 (62.3) | 181 (62.8) | 178 (61.8) |
| No | 217 (37.7) | 107 (37.2) | 110 (38.2) |
| Yes | 336 (58.3) | 163 (56.6) | 173 (60.1) |
| No | 240 (41.7) | 125 (43.4) | 115 (39.9) |
| Yes | 432 (75.0) | 209 (72.6) | 223 (77.4) |
| No | 79 (13.7) | 46 (16.0) | 33 (11.5) |
| Missing value | 65 (11.3) | 33 (11.4) | 32 (11.1) |
| 584.50±385.00 | 586.00±434.00 | 583.00±352.50 | |
| ≤ 3 | 348 (60.4) | 177 (61.5) | 171 (59.4) |
| > 3 | 228 (39.6) | 111 (38.5) | 117 (40.6) |
| Once a day | 331 (57.4) | 165 (57.3) | 166 (57.6) |
| Twice a day | 244 (42.4) | 122 (42.4) | 122 (42.4) |
| Missing value | 1 (0.2) | 1 (0.3) | 0 (0.0) |
| Three | 531 (92.2) | 265 (92.0) | 266 (92.4) |
| Two or one | 45 (7.8) | 23 (8.0) | 22 (7.6) |
| Yes | 545 (94.6) | 274 (95.1) | 271 (94.1) |
| No | 31 (5.4) | 14 (4.9) | 17 (5.9) |
| Yes | 527 (91.5) | 261 (90.6) | 266 (92.4) |
| No | 49 (8.5) | 27 (9.4) | 22 (7.6) |
| Yes | 357 (62.0) | 180 (62.5) | 177 (61.5) |
| No | 219 (38.0) | 108 (37.5) | 111 (38.5) |
Data are presented as no. (%) unless otherwise indicated
Abbreviations: ART antiretroviral therapy, USD United States dollars, IQR interquartile range
aHas told anyone (except homosexual partner) about sexual orientation or sexual history with men
bHas told anyone (except health providers in designated ART sites) about HIV positive-status
cDefined as undetectable viral load (i.e., < 20 copies/ml)
Fig. 4Proportions of achieving optimal ART adherence at baseline and two follow-ups. A Proportions of optimal ART adherence in total. B Proportions of optimal ART adherence in text message subgroup. C Proportions of optimal ART adherence in instant message subgroup. D Proportions of optimal ART adherence in instant message plus social media subgroup. ART, antiretroviral therapy
Fig. 5Effect of differentiated digital intervention on ART adherence among MSM living with HIV in China, 2020–2021. ART, antiretroviral therapy; RR, risk ratio; CI, confidence interval; ITT, intention-to-treat; PP, per-protocol; AT, as-treated
Effect of differentiated digital intervention on secondary outcomes using ITT analysis among MSM living with HIV in China, 2020–2021
| Differentiated digital intervention (Total) | Text message-based intervention | Instant message-based intervention | Instant message plus social media group intervention | |
|---|---|---|---|---|
| Viral suppressiona | 1.39 (0.64, 3.05) | 1.28 (0.15, 10.59) | 0.85 (0.27, 2.62) | 3.06 (0.70, 13.33) |
| CD4 T cell counts | − 1.55 (− 17.51, 14.42) | − 10.67 (− 39.38, 18.04) | 6.98 (− 14.87, 28.84) | − 5.81 (− 42.58, 30.95) |
| HIV treatment adherence self-efficacy | 1.41 (− 0.09, 2.92) | 1.24 (− 1.55, 4.02) | 1.67 (− 0.26, 3.61) | 0.27 (− 3.45, 3.99) |
| Quality of life | 0.47 (− 0.43, 1.36) | − 1.50 (− 3.24, 0.25) | 0.85 (− 0.43, 2.13) | 1.66 (− 0.16, 3.47) |
Abbreviations: ITT intention-to-treat, RR risk ratio, MD mean difference, CI confidence interval, MSM men who have sex with men
aDefined as undetectable viral load (i.e., < 20 copies/ml)